Egetis Therapeutics — Major Shareholding Notification 2021

Sep 14, 2021

Issuer Egetis Therapeutics AB (publ)

Holder

Cidro Förvaltning AB

Instrument

Instrument	Aktie
Before the transaction
Shares	12,124,820
Voting rights	12,124,820
Transaction
Date	13/09/2021
Limit for number of shares 10 %
Limit for number of votes	10 %

After the transaction

Quantity

Shares	16,524,820
Directly held voting rights 16,524,820
Indirectly held voting rights 16,524,820
Percentage
Directly held shares	10.01 %

Directly held voting rights 10.01 % Indirectly held voting rights 10.01 %

Resulting distribution of total

holdings
	Percentage of voting rights:	Number of underlying shares:
Shares	20.02 %	16,524,820
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	20.02 %	16,524,820
Group total holdings
Voting rights 16,524,820
Percentage of voting rights 10.01
Published
14/09/2021 10:53
Contact
Name Peter Lindell
Phone 0708496659 Email peter.lindell@riteventures.com

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25